

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to kinetochore (GO:0034501) | 5.19275500 |
| 2 | positive regulation of histone deacetylation (GO:0031065) | 4.61484700 |
| 3 | daunorubicin metabolic process (GO:0044597) | 4.33696621 |
| 4 | polyketide metabolic process (GO:0030638) | 4.33696621 |
| 5 | doxorubicin metabolic process (GO:0044598) | 4.33696621 |
| 6 | interferon-gamma production (GO:0032609) | 4.24979111 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.23394259 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.23394259 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.23394259 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.23394259 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.23394259 |
| 12 | protein localization to chromosome, centromeric region (GO:0071459) | 4.23393589 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19707495 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 4.12400171 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.05585135 |
| 16 | positive regulation of protein deacetylation (GO:0090312) | 4.02751624 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.01407016 |
| 18 | negative T cell selection (GO:0043383) | 4.00060494 |
| 19 | detection of other organism (GO:0098543) | 3.74315608 |
| 20 | cellular extravasation (GO:0045123) | 3.74085805 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.71786143 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.68699031 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67076085 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65200967 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.65197918 |
| 26 | mitotic sister chromatid segregation (GO:0000070) | 3.64858208 |
| 27 | positive T cell selection (GO:0043368) | 3.63468490 |
| 28 | detection of bacterium (GO:0016045) | 3.59536160 |
| 29 | nuclear pore complex assembly (GO:0051292) | 3.57836226 |
| 30 | T cell migration (GO:0072678) | 3.57743394 |
| 31 | heterochromatin organization (GO:0070828) | 3.56776972 |
| 32 | sister chromatid segregation (GO:0000819) | 3.54550235 |
| 33 | response to interleukin-15 (GO:0070672) | 3.51755217 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45835770 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44482847 |
| 36 | positive regulation of granulocyte differentiation (GO:0030854) | 3.44191936 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41920480 |
| 38 | T cell selection (GO:0045058) | 3.40367580 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.39935971 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39935971 |
| 41 | maintenance of protein location in nucleus (GO:0051457) | 3.37722664 |
| 42 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.35870428 |
| 43 | chromatin assembly (GO:0031497) | 3.35130965 |
| 44 | regulation of response to osmotic stress (GO:0047484) | 3.33711188 |
| 45 | germinal center formation (GO:0002467) | 3.28602082 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28003152 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.25080352 |
| 48 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.24426044 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.22348117 |
| 50 | thymic T cell selection (GO:0045061) | 3.22248524 |
| 51 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21869814 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.18029322 |
| 53 | mRNA stabilization (GO:0048255) | 3.16442079 |
| 54 | RNA stabilization (GO:0043489) | 3.16442079 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 3.15566095 |
| 56 | activated T cell proliferation (GO:0050798) | 3.12052047 |
| 57 | response to type I interferon (GO:0034340) | 3.10145364 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08505190 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07285395 |
| 60 | microglial cell activation (GO:0001774) | 3.07194173 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.06536826 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.04374088 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.04374088 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04044819 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.02743242 |
| 66 | muscle organ morphogenesis (GO:0048644) | 3.02435426 |
| 67 | mitotic chromosome condensation (GO:0007076) | 3.02101887 |
| 68 | pore complex assembly (GO:0046931) | 2.95136772 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92546806 |
| 70 | regulation of granulocyte differentiation (GO:0030852) | 2.92526990 |
| 71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.92107539 |
| 72 | nuclear pore organization (GO:0006999) | 2.91472481 |
| 73 | defense response to protozoan (GO:0042832) | 2.90547369 |
| 74 | natural killer cell differentiation (GO:0001779) | 2.90356929 |
| 75 | response to host immune response (GO:0052572) | 2.90147606 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90147606 |
| 77 | megakaryocyte development (GO:0035855) | 2.89861755 |
| 78 | regulation of tolerance induction (GO:0002643) | 2.88938347 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.88363373 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88201959 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88059804 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.87162900 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86052859 |
| 84 | positive thymic T cell selection (GO:0045059) | 2.85805657 |
| 85 | B cell homeostasis (GO:0001782) | 2.85236037 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80925071 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80925071 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 2.80603558 |
| 89 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.79172648 |
| 90 | Peyers patch development (GO:0048541) | 2.79172648 |
| 91 | regulation of necroptotic process (GO:0060544) | 2.77936807 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.77853887 |
| 93 | macrophage activation (GO:0042116) | 2.77367571 |
| 94 | response to protozoan (GO:0001562) | 2.76969948 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.76958918 |
| 96 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.76096688 |
| 97 | negative regulation of bone resorption (GO:0045779) | 2.75495096 |
| 98 | positive regulation of tolerance induction (GO:0002645) | 2.74124200 |
| 99 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.73891494 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73353278 |
| 101 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73144024 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72637041 |
| 103 | response to host (GO:0075136) | 2.72335352 |
| 104 | response to host defenses (GO:0052200) | 2.72335352 |
| 105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72335352 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.71598325 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70255984 |
| 108 | DNA unwinding involved in DNA replication (GO:0006268) | 2.69457546 |
| 109 | positive regulation of interferon-alpha production (GO:0032727) | 2.69427461 |
| 110 | adaptation of signaling pathway (GO:0023058) | 2.67882447 |
| 111 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67880948 |
| 112 | histone H4-K8 acetylation (GO:0043982) | 2.67445834 |
| 113 | histone H4-K5 acetylation (GO:0043981) | 2.67445834 |
| 114 | neutrophil activation (GO:0042119) | 2.66289605 |
| 115 | regulation of B cell differentiation (GO:0045577) | 2.66056815 |
| 116 | DNA duplex unwinding (GO:0032508) | 2.65853964 |
| 117 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65294576 |
| 118 | DNA geometric change (GO:0032392) | 2.64753740 |
| 119 | NLS-bearing protein import into nucleus (GO:0006607) | 2.63520269 |
| 120 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63199162 |
| 121 | regulation of interferon-alpha production (GO:0032647) | 2.62991424 |
| 122 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62403281 |
| 123 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62280403 |
| 124 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62280403 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 2.61244951 |
| 126 | positive regulation of isotype switching (GO:0045830) | 2.60935153 |
| 127 | response to laminar fluid shear stress (GO:0034616) | 2.59834873 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.59486138 |
| 129 | establishment of endothelial barrier (GO:0061028) | 2.58919030 |
| 130 | apoptotic cell clearance (GO:0043277) | 2.56753830 |
| 131 | maternal placenta development (GO:0001893) | 2.56077457 |
| 132 | negative regulation of telomerase activity (GO:0051974) | 2.55309988 |
| 133 | cytidine metabolic process (GO:0046087) | 2.54361634 |
| 134 | cytidine catabolic process (GO:0006216) | 2.54361634 |
| 135 | cytidine deamination (GO:0009972) | 2.54361634 |
| 136 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.53649191 |
| 137 | B cell receptor signaling pathway (GO:0050853) | 2.53090122 |
| 138 | histone H4-K16 acetylation (GO:0043984) | 2.51437534 |
| 139 | pinocytosis (GO:0006907) | 2.50950883 |
| 140 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.50875446 |
| 141 | tachykinin receptor signaling pathway (GO:0007217) | 2.48458099 |
| 142 | cellular hyperosmotic response (GO:0071474) | 2.48259868 |
| 143 | phagocytosis, recognition (GO:0006910) | 2.48238920 |
| 144 | natural killer cell activation (GO:0030101) | 2.46919835 |
| 145 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.43930799 |
| 146 | response to UV-C (GO:0010225) | 2.42118836 |
| 147 | regulation of apoptotic cell clearance (GO:2000425) | 2.40614623 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.40123187 |
| 149 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.40123187 |
| 150 | negative regulation of necroptotic process (GO:0060546) | 2.39653860 |
| 151 | hepatocyte apoptotic process (GO:0097284) | 2.38784860 |
| 152 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38417032 |
| 153 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.37971513 |
| 154 | leukocyte aggregation (GO:0070486) | 2.37143319 |
| 155 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.36245320 |
| 156 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35890765 |
| 157 | histone H3-K4 methylation (GO:0051568) | 2.35608338 |
| 158 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34959014 |
| 159 | tolerance induction (GO:0002507) | 2.34896418 |
| 160 | modulation by symbiont of host cellular process (GO:0044068) | 2.34202277 |
| 161 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.33423090 |
| 162 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.33289032 |
| 163 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.33097129 |
| 164 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.32541598 |
| 165 | negative regulation of epidermis development (GO:0045683) | 2.31513336 |
| 166 | regulation of histone deacetylation (GO:0031063) | 2.29595557 |
| 167 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.29262042 |
| 168 | natural killer cell mediated immunity (GO:0002228) | 2.29262042 |
| 169 | negative regulation of bone remodeling (GO:0046851) | 2.28745431 |
| 170 | positive regulation of bone remodeling (GO:0046852) | 2.28147636 |
| 171 | positive regulation of bone resorption (GO:0045780) | 2.28147636 |
| 172 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.27900543 |
| 173 | response to peptidoglycan (GO:0032494) | 2.27802964 |
| 174 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.27524059 |
| 175 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.27481245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.11149468 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.95566349 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.91393397 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.13137870 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09643461 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81596663 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79289617 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68447191 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.67801785 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62999179 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50683526 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43108741 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33178642 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27057575 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24781402 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.23190938 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.10925516 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09027698 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08704100 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03393661 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97120018 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.96940737 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.96940737 |
| 24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.96940737 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90661204 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.88078814 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81666138 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79325288 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77926462 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77282939 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75793470 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.74956537 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73418714 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.72104186 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71862934 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70918108 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68945128 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67810529 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66472770 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60719554 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59542897 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58559404 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55390525 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54971683 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54431949 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53604645 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53539725 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53096179 |
| 49 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.52611958 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52069069 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50449907 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50228600 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46409063 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46134735 |
| 55 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.44299487 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43090126 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42708679 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42073945 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41371170 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39842964 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38970132 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34580665 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32623364 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31944411 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31869274 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29331430 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29129845 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28465044 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28449353 |
| 70 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.26761946 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25742052 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24312037 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22436738 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.18910232 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17693946 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16999284 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16663459 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16496596 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14438159 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12834609 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12827573 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07497577 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05410974 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04933768 |
| 85 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02628611 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02195104 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01708583 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01694786 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01485119 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97245075 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96687188 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94825468 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94465286 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94407793 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94363088 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93933363 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93865381 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93015557 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92511497 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92296613 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92007658 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91661171 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89297576 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89060553 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88888912 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88742718 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88319860 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88046873 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87924353 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86456819 |
| 111 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85519136 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84435544 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84089277 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83854831 |
| 115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81570555 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80401026 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80182469 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79839462 |
| 119 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79813885 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79590379 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79431175 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79318529 |
| 123 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78977540 |
| 124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77977918 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76784826 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67372541 |
| 127 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65698192 |
| 128 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.65398133 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64121741 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.62558484 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.60756288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.66457306 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.25716403 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.63309909 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 2.56483881 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.42991729 |
| 6 | MP0003011_delayed_dark_adaptation | 2.30191593 |
| 7 | MP0003436_decreased_susceptibility_to | 2.22302794 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.21997797 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.10582819 |
| 10 | MP0001800_abnormal_humoral_immune | 2.07272439 |
| 11 | MP0000685_abnormal_immune_system | 2.04452252 |
| 12 | MP0009278_abnormal_bone_marrow | 2.03239552 |
| 13 | MP0003303_peritoneal_inflammation | 1.97503479 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 1.96982709 |
| 15 | MP0001790_abnormal_immune_system | 1.95120591 |
| 16 | MP0005387_immune_system_phenotype | 1.95120591 |
| 17 | MP0008057_abnormal_DNA_replication | 1.92854994 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.91599436 |
| 19 | MP0006082_CNS_inflammation | 1.89476846 |
| 20 | MP0002398_abnormal_bone_marrow | 1.75553847 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.72523423 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.71160342 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 1.69058583 |
| 24 | MP0010307_abnormal_tumor_latency | 1.67718141 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.66199743 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.66199743 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.64745217 |
| 28 | MP0005671_abnormal_response_to | 1.64396942 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.63952249 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.62224358 |
| 31 | MP0002405_respiratory_system_inflammati | 1.61661709 |
| 32 | MP0004130_abnormal_muscle_cell | 1.61653525 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.61568665 |
| 34 | MP0002722_abnormal_immune_system | 1.59961289 |
| 35 | MP0001819_abnormal_immune_cell | 1.59655333 |
| 36 | MP0005257_abnormal_intraocular_pressure | 1.58876023 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.58017321 |
| 38 | MP0002723_abnormal_immune_serum | 1.56764103 |
| 39 | MP0002254_reproductive_system_inflammat | 1.55755629 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.54216558 |
| 41 | MP0004947_skin_inflammation | 1.53434831 |
| 42 | MP0005023_abnormal_wound_healing | 1.51283243 |
| 43 | MP0005025_abnormal_response_to | 1.50361966 |
| 44 | MP0004381_abnormal_hair_follicle | 1.49547619 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.48155580 |
| 46 | MP0000716_abnormal_immune_system | 1.48044077 |
| 47 | MP0003448_altered_tumor_morphology | 1.46840061 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.44207090 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.43796489 |
| 50 | MP0002933_joint_inflammation | 1.41633327 |
| 51 | MP0002009_preneoplasia | 1.41427890 |
| 52 | MP0002429_abnormal_blood_cell | 1.38282924 |
| 53 | MP0002419_abnormal_innate_immunity | 1.37777003 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.36157978 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.35702342 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.35151190 |
| 57 | MP0000490_abnormal_crypts_of | 1.35108644 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.34653523 |
| 59 | MP0003077_abnormal_cell_cycle | 1.34504617 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.34070252 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.31021333 |
| 62 | MP0009764_decreased_sensitivity_to | 1.29156735 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.28150517 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.27864834 |
| 65 | MP0003091_abnormal_cell_migration | 1.25845454 |
| 66 | MP0000858_altered_metastatic_potential | 1.23958354 |
| 67 | MP0009785_altered_susceptibility_to | 1.22161878 |
| 68 | MP0008469_abnormal_protein_level | 1.19161851 |
| 69 | MP0001851_eye_inflammation | 1.18867604 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.18542417 |
| 71 | MP0003866_abnormal_defecation | 1.17962900 |
| 72 | MP0004883_abnormal_blood_vessel | 1.17763526 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.17741608 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.17640215 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.15960503 |
| 76 | MP0002006_tumorigenesis | 1.14286606 |
| 77 | MP0003279_aneurysm | 1.13962450 |
| 78 | MP0000350_abnormal_cell_proliferation | 1.13907772 |
| 79 | MP0004510_myositis | 1.10781997 |
| 80 | MP0001243_abnormal_dermal_layer | 1.10199974 |
| 81 | MP0010094_abnormal_chromosome_stability | 1.09107701 |
| 82 | MP0002019_abnormal_tumor_incidence | 1.08609225 |
| 83 | MP0005164_abnormal_response_to | 1.08518489 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 1.07279739 |
| 85 | MP0005451_abnormal_body_composition | 1.06750489 |
| 86 | MP0003984_embryonic_growth_retardation | 1.06224246 |
| 87 | MP0002332_abnormal_exercise_endurance | 1.05209510 |
| 88 | MP0001853_heart_inflammation | 1.04585207 |
| 89 | MP0001672_abnormal_embryogenesis/_devel | 1.03847910 |
| 90 | MP0005380_embryogenesis_phenotype | 1.03847910 |
| 91 | MP0005670_abnormal_white_adipose | 1.02824417 |
| 92 | MP0000733_abnormal_muscle_development | 1.02131325 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.01366148 |
| 94 | MP0002086_abnormal_extraembryonic_tissu | 0.97036644 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.96834897 |
| 96 | MP0008260_abnormal_autophagy | 0.96023765 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.95316133 |
| 98 | MP0000249_abnormal_blood_vessel | 0.94752861 |
| 99 | MP0001958_emphysema | 0.94649337 |
| 100 | MP0002970_abnormal_white_adipose | 0.91760094 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.90725956 |
| 102 | MP0003828_pulmonary_edema | 0.89934928 |
| 103 | MP0001873_stomach_inflammation | 0.88879037 |
| 104 | MP0002971_abnormal_brown_adipose | 0.88216355 |
| 105 | MP0000343_altered_response_to | 0.87544567 |
| 106 | MP0002060_abnormal_skin_morphology | 0.87186414 |
| 107 | MP0003690_abnormal_glial_cell | 0.85752321 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.85324546 |
| 109 | MP0009115_abnormal_fat_cell | 0.84063275 |
| 110 | MP0008770_decreased_survivor_rate | 0.83876284 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.83835370 |
| 112 | MP0000313_abnormal_cell_death | 0.83664241 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.83302442 |
| 114 | MP0002148_abnormal_hypersensitivity_rea | 0.83251126 |
| 115 | MP0005390_skeleton_phenotype | 0.83136664 |
| 116 | MP0002132_abnormal_respiratory_system | 0.81814413 |
| 117 | MP0005621_abnormal_cell_physiology | 0.81805398 |
| 118 | MP0001915_intracranial_hemorrhage | 0.81724520 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.80982344 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.80257743 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.79471046 |
| 122 | MP0003045_fibrosis | 0.79070973 |
| 123 | MP0009763_increased_sensitivity_to | 0.78398006 |
| 124 | MP0000609_abnormal_liver_physiology | 0.78321383 |
| 125 | MP0005310_abnormal_salivary_gland | 0.78305103 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.77953497 |
| 127 | MP0000371_diluted_coat_color | 0.76875964 |
| 128 | MP0008004_abnormal_stomach_pH | 0.76390658 |
| 129 | MP0003075_altered_response_to | 0.75952332 |
| 130 | MP0003646_muscle_fatigue | 0.74849561 |
| 131 | MP0001663_abnormal_digestive_system | 0.72234024 |
| 132 | MP0000604_amyloidosis | 0.67710439 |
| 133 | MP0005334_abnormal_fat_pad | 0.67268785 |
| 134 | MP0005535_abnormal_body_temperature | 0.66059377 |
| 135 | MP0005166_decreased_susceptibility_to | 0.65022280 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.64695090 |
| 137 | MP0001986_abnormal_taste_sensitivity | 0.63236591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 4.16148483 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.16148483 |
| 3 | Stomatitis (HP:0010280) | 3.91722839 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 3.76083686 |
| 5 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.76083686 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 3.60131646 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.55635104 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 3.42691726 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.38555676 |
| 10 | Recurrent skin infections (HP:0001581) | 3.33305075 |
| 11 | Keratoconjunctivitis sicca (HP:0001097) | 3.33138715 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28104515 |
| 13 | Cellulitis (HP:0100658) | 3.25615118 |
| 14 | Increased connective tissue (HP:0009025) | 3.15333283 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.13488266 |
| 16 | Encephalitis (HP:0002383) | 3.11897518 |
| 17 | Pulmonary infiltrates (HP:0002113) | 3.05997627 |
| 18 | Nasal polyposis (HP:0100582) | 3.04513092 |
| 19 | Peritonitis (HP:0002586) | 2.98890451 |
| 20 | Granulocytopenia (HP:0001913) | 2.87896075 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 2.85125873 |
| 22 | Eosinophilia (HP:0001880) | 2.82744525 |
| 23 | Myositis (HP:0100614) | 2.81999521 |
| 24 | Hemoptysis (HP:0002105) | 2.81605248 |
| 25 | Increased IgE level (HP:0003212) | 2.78150463 |
| 26 | Gastrointestinal stroma tumor (HP:0100723) | 2.78005968 |
| 27 | Absent frontal sinuses (HP:0002688) | 2.76574653 |
| 28 | Multiple enchondromatosis (HP:0005701) | 2.70098821 |
| 29 | Abnormality of B cell number (HP:0010975) | 2.68358289 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66772487 |
| 31 | Ulnar bowing (HP:0003031) | 2.66225502 |
| 32 | Protrusio acetabuli (HP:0003179) | 2.61354736 |
| 33 | Recurrent viral infections (HP:0004429) | 2.60447510 |
| 34 | Bilateral microphthalmos (HP:0007633) | 2.58310763 |
| 35 | Hematochezia (HP:0002573) | 2.58282322 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.55265940 |
| 37 | Hypochromic anemia (HP:0001931) | 2.54529450 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.54092779 |
| 39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54092779 |
| 40 | Lymphopenia (HP:0001888) | 2.54077585 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.53617796 |
| 42 | Arterial thrombosis (HP:0004420) | 2.48848056 |
| 43 | Obstructive lung disease (HP:0006536) | 2.47898718 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47898718 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.46118467 |
| 46 | Increased density of long bones (HP:0006392) | 2.39639482 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38758282 |
| 48 | Premature rupture of membranes (HP:0001788) | 2.35915125 |
| 49 | Periodontitis (HP:0000704) | 2.35137089 |
| 50 | Urticaria (HP:0001025) | 2.34461369 |
| 51 | Orchitis (HP:0100796) | 2.33573276 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.30280006 |
| 53 | Abnormality of the fingertips (HP:0001211) | 2.29716975 |
| 54 | Pulmonary embolism (HP:0002204) | 2.29492673 |
| 55 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.29432963 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.29149401 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.27687762 |
| 58 | Mitral valve prolapse (HP:0001634) | 2.27375927 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.25772461 |
| 60 | IgG deficiency (HP:0004315) | 2.22727519 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21799177 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.18357839 |
| 63 | Ankle contracture (HP:0006466) | 2.17593220 |
| 64 | Chromsome breakage (HP:0040012) | 2.16984453 |
| 65 | Myocardial infarction (HP:0001658) | 2.15291428 |
| 66 | Viral hepatitis (HP:0006562) | 2.14268557 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.13682813 |
| 68 | B lymphocytopenia (HP:0010976) | 2.13323776 |
| 69 | Abnormal platelet volume (HP:0011876) | 2.11448505 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.09446825 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.08892570 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.08760145 |
| 73 | Amyloidosis (HP:0011034) | 2.07457201 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07274828 |
| 75 | Abnormality of the lower motor neuron (HP:0002366) | 2.07163908 |
| 76 | Macroorchidism (HP:0000053) | 2.06836496 |
| 77 | Chest pain (HP:0100749) | 2.06578455 |
| 78 | Thyroiditis (HP:0100646) | 2.06025217 |
| 79 | Gingivitis (HP:0000230) | 2.05584330 |
| 80 | Hypoplasia of the thymus (HP:0000778) | 2.05462882 |
| 81 | Prolonged bleeding time (HP:0003010) | 2.05179759 |
| 82 | Microcytic anemia (HP:0001935) | 2.03821685 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03440572 |
| 84 | Hand muscle atrophy (HP:0009130) | 2.01930101 |
| 85 | Colitis (HP:0002583) | 2.01437486 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01256506 |
| 87 | Ependymoma (HP:0002888) | 2.01048238 |
| 88 | Papilledema (HP:0001085) | 2.00403512 |
| 89 | Upper limb amyotrophy (HP:0009129) | 2.00004664 |
| 90 | Distal upper limb amyotrophy (HP:0007149) | 2.00004664 |
| 91 | Large earlobe (HP:0009748) | 1.99222819 |
| 92 | Increased IgM level (HP:0003496) | 1.99122402 |
| 93 | Rib fusion (HP:0000902) | 1.98728057 |
| 94 | Gingival bleeding (HP:0000225) | 1.97454417 |
| 95 | Spondylolisthesis (HP:0003302) | 1.97394144 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97112374 |
| 97 | Dislocated radial head (HP:0003083) | 1.95752445 |
| 98 | Syringomyelia (HP:0003396) | 1.95272164 |
| 99 | Spinal cord lesions (HP:0100561) | 1.95272164 |
| 100 | IgA deficiency (HP:0002720) | 1.94946151 |
| 101 | Recurrent bronchitis (HP:0002837) | 1.94355997 |
| 102 | Recurrent pneumonia (HP:0006532) | 1.94337659 |
| 103 | Prominent nose (HP:0000448) | 1.94280309 |
| 104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93470346 |
| 105 | Inflammation of the large intestine (HP:0002037) | 1.93296393 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 1.90507107 |
| 107 | Skin tags (HP:0010609) | 1.90484697 |
| 108 | Gangrene (HP:0100758) | 1.89446024 |
| 109 | Episodic fever (HP:0001954) | 1.89402713 |
| 110 | Chronic diarrhea (HP:0002028) | 1.88352172 |
| 111 | T lymphocytopenia (HP:0005403) | 1.87860920 |
| 112 | Sepsis (HP:0100806) | 1.87796513 |
| 113 | IgM deficiency (HP:0002850) | 1.87744037 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.87670615 |
| 115 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87435984 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87435984 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87435984 |
| 118 | Keratitis (HP:0000491) | 1.87229973 |
| 119 | Heterotopia (HP:0002282) | 1.86972034 |
| 120 | Increased mean platelet volume (HP:0011877) | 1.85455682 |
| 121 | Preauricular skin tag (HP:0000384) | 1.83974450 |
| 122 | Petechiae (HP:0000967) | 1.83829452 |
| 123 | Meningitis (HP:0001287) | 1.83584744 |
| 124 | Cheilitis (HP:0100825) | 1.83269710 |
| 125 | Radial bowing (HP:0002986) | 1.82616514 |
| 126 | Panhypogammaglobulinemia (HP:0003139) | 1.82574994 |
| 127 | Leukocytosis (HP:0001974) | 1.82178385 |
| 128 | Pustule (HP:0200039) | 1.81860397 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 1.81528440 |
| 130 | Broad palm (HP:0001169) | 1.81227223 |
| 131 | Abnormality of the peritoneum (HP:0002585) | 1.80354809 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.80135488 |
| 133 | Cervical subluxation (HP:0003308) | 1.79073041 |
| 134 | Increased serum ferritin (HP:0003281) | 1.77887610 |
| 135 | Dilatation of the ascending aorta (HP:0005111) | 1.77874383 |
| 136 | Abnormality of the radial head (HP:0003995) | 1.77828849 |
| 137 | Osteomyelitis (HP:0002754) | 1.76947773 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.76255743 |
| 139 | Abnormal platelet function (HP:0011869) | 1.76255743 |
| 140 | Papilloma (HP:0012740) | 1.75432176 |
| 141 | Verrucae (HP:0200043) | 1.75432176 |
| 142 | Epistaxis (HP:0000421) | 1.73720855 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.73168049 |
| 144 | Emphysema (HP:0002097) | 1.72797902 |
| 145 | Neoplasm of striated muscle (HP:0009728) | 1.72725603 |
| 146 | Vasculitis (HP:0002633) | 1.72152462 |
| 147 | Genu recurvatum (HP:0002816) | 1.71929393 |
| 148 | Hepatoblastoma (HP:0002884) | 1.71646569 |
| 149 | Difficulty running (HP:0009046) | 1.71242047 |
| 150 | Disproportionate tall stature (HP:0001519) | 1.70726021 |
| 151 | Abnormality of T cell physiology (HP:0011840) | 1.69291148 |
| 152 | Restrictive lung disease (HP:0002091) | 1.67393404 |
| 153 | Short 5th finger (HP:0009237) | 1.65484515 |
| 154 | Abnormality of T cells (HP:0002843) | 1.65413920 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.64961324 |
| 156 | Spontaneous hematomas (HP:0007420) | 1.63995266 |
| 157 | Myelodysplasia (HP:0002863) | 1.63928425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.74265699 |
| 2 | ERN1 | 3.87534061 |
| 3 | RIPK4 | 3.36620917 |
| 4 | GRK6 | 3.16085674 |
| 5 | PRPF4B | 2.94504865 |
| 6 | EEF2K | 2.81159968 |
| 7 | MAP3K10 | 2.80686434 |
| 8 | STK10 | 2.77827339 |
| 9 | MAP4K1 | 2.69651997 |
| 10 | CSF1R | 2.60837124 |
| 11 | TRIB3 | 2.48609153 |
| 12 | TGFBR2 | 1.93357645 |
| 13 | TTN | 1.82310134 |
| 14 | PKN2 | 1.75215603 |
| 15 | GRK5 | 1.74513122 |
| 16 | MAP3K13 | 1.65446113 |
| 17 | NEK2 | 1.51000649 |
| 18 | KIT | 1.46989822 |
| 19 | FRK | 1.46885513 |
| 20 | GRK1 | 1.38762610 |
| 21 | CAMK1D | 1.34976363 |
| 22 | TTK | 1.34537888 |
| 23 | FGFR3 | 1.32301775 |
| 24 | JAK3 | 1.31831806 |
| 25 | TYK2 | 1.27662708 |
| 26 | MOS | 1.25899389 |
| 27 | MAPK7 | 1.25180153 |
| 28 | RIPK1 | 1.23185552 |
| 29 | ITK | 1.22545823 |
| 30 | SIK1 | 1.21844292 |
| 31 | CSK | 1.20396263 |
| 32 | MAP3K3 | 1.20184237 |
| 33 | SIK2 | 1.17380811 |
| 34 | TAOK3 | 1.16471374 |
| 35 | MAP2K3 | 1.13577156 |
| 36 | MATK | 1.12914681 |
| 37 | CDC42BPA | 1.11806044 |
| 38 | NLK | 1.09055550 |
| 39 | PIK3CG | 1.07463234 |
| 40 | PAK4 | 1.06290998 |
| 41 | ZAP70 | 1.04557500 |
| 42 | LRRK2 | 1.03559836 |
| 43 | BLK | 1.02304067 |
| 44 | TRPM7 | 1.01818587 |
| 45 | PIM1 | 1.01469420 |
| 46 | JAK1 | 1.00786830 |
| 47 | IKBKB | 1.00086871 |
| 48 | CDK4 | 0.99709340 |
| 49 | ADRBK2 | 0.97846988 |
| 50 | EPHB1 | 0.97627709 |
| 51 | HCK | 0.97218652 |
| 52 | MAP3K14 | 0.94202186 |
| 53 | IRAK1 | 0.91943625 |
| 54 | MTOR | 0.91085052 |
| 55 | CAMKK2 | 0.90439650 |
| 56 | PTK6 | 0.90300390 |
| 57 | HIPK2 | 0.89102716 |
| 58 | MAP3K7 | 0.87561678 |
| 59 | STK4 | 0.87440774 |
| 60 | TBK1 | 0.87027910 |
| 61 | BMPR2 | 0.85753422 |
| 62 | PDK1 | 0.85414945 |
| 63 | MARK2 | 0.85372635 |
| 64 | MAP3K1 | 0.85269448 |
| 65 | CDK7 | 0.84145312 |
| 66 | WNK1 | 0.82878039 |
| 67 | SYK | 0.82667009 |
| 68 | BTK | 0.81931418 |
| 69 | ALK | 0.81824648 |
| 70 | CDC7 | 0.81451968 |
| 71 | CHUK | 0.81301688 |
| 72 | IRAK3 | 0.80491161 |
| 73 | PRKCQ | 0.80070135 |
| 74 | CDK6 | 0.79630996 |
| 75 | STK3 | 0.79342750 |
| 76 | CAMK1G | 0.79332149 |
| 77 | SGK2 | 0.79115701 |
| 78 | BMX | 0.78692513 |
| 79 | FGR | 0.78262016 |
| 80 | MAP3K11 | 0.78247667 |
| 81 | LCK | 0.75285412 |
| 82 | CAMKK1 | 0.74758279 |
| 83 | CLK1 | 0.74325283 |
| 84 | TYRO3 | 0.73121724 |
| 85 | RPS6KA4 | 0.70861487 |
| 86 | PTK2B | 0.69966263 |
| 87 | SGK3 | 0.68433847 |
| 88 | PRKD2 | 0.68368201 |
| 89 | CAMK4 | 0.66266100 |
| 90 | MAP3K6 | 0.64868665 |
| 91 | PDPK1 | 0.64596737 |
| 92 | GRK7 | 0.64438654 |
| 93 | PRKG2 | 0.63087039 |
| 94 | EPHA3 | 0.62462550 |
| 95 | PRKAA2 | 0.61529916 |
| 96 | FGFR4 | 0.61429394 |
| 97 | TXK | 0.60945907 |
| 98 | MAPK12 | 0.60529388 |
| 99 | MELK | 0.60146069 |
| 100 | RPS6KB2 | 0.60041507 |
| 101 | FLT3 | 0.57844629 |
| 102 | CHEK2 | 0.57291522 |
| 103 | MAP3K8 | 0.57238789 |
| 104 | JAK2 | 0.57189967 |
| 105 | CHEK1 | 0.53476862 |
| 106 | MARK3 | 0.52903726 |
| 107 | NEK9 | 0.51895632 |
| 108 | PDGFRA | 0.51879397 |
| 109 | YES1 | 0.50290826 |
| 110 | PAK2 | 0.49301380 |
| 111 | AURKB | 0.49175700 |
| 112 | RPS6KA6 | 0.48962078 |
| 113 | PLK1 | 0.48772712 |
| 114 | IRAK4 | 0.46392765 |
| 115 | PDGFRB | 0.46315873 |
| 116 | IKBKE | 0.45603713 |
| 117 | RPS6KC1 | 0.44701141 |
| 118 | RPS6KL1 | 0.44701141 |
| 119 | RET | 0.44184536 |
| 120 | FES | 0.43433709 |
| 121 | SIK3 | 0.42490582 |
| 122 | BRD4 | 0.42413849 |
| 123 | LYN | 0.41951783 |
| 124 | MAPK11 | 0.39479753 |
| 125 | IRAK2 | 0.39467705 |
| 126 | CDK9 | 0.39156652 |
| 127 | ATR | 0.38788639 |
| 128 | MAPK4 | 0.38187820 |
| 129 | TEC | 0.37710513 |
| 130 | PRKCH | 0.37557619 |
| 131 | TNK2 | 0.37557408 |
| 132 | DDR2 | 0.37275230 |
| 133 | TAOK2 | 0.37249406 |
| 134 | FYN | 0.36760538 |
| 135 | MAPKAPK2 | 0.36454466 |
| 136 | ABL1 | 0.36337579 |
| 137 | MAPK3 | 0.36193997 |
| 138 | TAOK1 | 0.35952917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25669513 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.22747422 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22501289 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13506084 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96318121 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96244434 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.94422252 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93626719 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77745292 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75119899 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72125790 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61921600 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.61487017 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61139549 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60353796 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.51050093 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.49167288 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47965894 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42744445 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41145232 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41142998 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.40522692 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.37620791 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36338781 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33857324 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33783253 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33746680 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33185515 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33079876 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32216220 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30749515 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28532504 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27179014 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26515534 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26210688 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19811569 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16569517 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14738716 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14299778 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14122502 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.12546558 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.10769162 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09357564 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09231128 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 1.09144812 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08708636 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07109960 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.04864528 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.04661370 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01962457 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01427840 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01293853 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.00127376 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99753199 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98797670 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98667247 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.98362709 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97831413 |
| 59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96515160 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95698176 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94970536 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93090256 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91524869 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.90601032 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90352090 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90219824 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.88579358 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.87285415 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86240109 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84434735 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83550487 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83117914 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81331023 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.80025433 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79221261 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78428141 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77601221 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76645327 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76606909 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.76106568 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.74846493 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74815784 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73428543 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71662303 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69975011 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69493945 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68935948 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.68909534 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.68360053 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.67774327 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67139231 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66770992 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66622314 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65327013 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64756564 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64326291 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63781001 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63174089 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61331448 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61015710 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60850464 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60290325 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.60232672 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59906283 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57959301 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57786508 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56687712 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56338900 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56005382 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.54352404 |
| 111 | RNA transport_Homo sapiens_hsa03013 | 0.54186125 |
| 112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53355789 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.52867578 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52359851 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51623962 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51177213 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51057685 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.50566269 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50412462 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.50063892 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49727621 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48665629 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45138986 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44176034 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42373350 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42339849 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38034499 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37429856 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.34537234 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34509835 |

